BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Datavant Inc.

Headquarters: San Francisco, CA, United States
Year Founded: 2021
Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Nov 3, 2023
Product Development

Tokenization: lowering barriers to evidence generation 

Linking data sources via tokenization will change the way clinical data are collected and interpreted
BioCentury | Jun 10, 2021
Deals

June 9 Quick Takes: Datavant, Ciox in health data merger; plus G7 plan, WTO, Merck and more

Datavant Inc. and Ciox Health believe their merger will create a health data network that will improve patient outcomes and reduce costs, overcoming data fragmentation by building a unified ecosystem.
BioCentury | Dec 5, 2020
Management Tracks

CureVac hires GSK Vaccines veteran Blanc as CBO and chief commercial officer; plus moves at Spero, 4D, Transgene, Achilles and Datavant

mRNA play CureVac N.V. (NASDAQ:CVAC) hired Antony Blanc as CBO and chief commercial officer. Blanc most recently was managing director at Clarentis s.r.l., and prior to that VP, global
BioCentury | Oct 6, 2020
Product Development

Reversing the impact of COVID-19 on oncology clinical trials: Guest Commentary

Wide-scale adoption of decentralized clinical trials would have benefits  far beyond insulation from COVID-19 
BioCentury | Aug 31, 2018
Financial News

Real-world data play RDMD raises $3M seed round

BioCentury | Aug 20, 2018
Financial News

Real-world data play RDMD raises $3M seed round

BioCentury | Jul 16, 2018
Finance

AI on the Verge

Why machine learning play Verge sought a multidisciplinary investor syndicate
Items per page:
1 - 10 of 16